Monday, August 1st at 11am eastern

PPMD will host a webinar on Monday, August 1 at 11am eastern with PTC Therapeutics to discuss the latest news regarding Translarna. Craig McDonald will present the benefits of Translarna from emerging data and senior leadership from PTC will be on hand to answer questions regarding the path forward for the therapy with the FDA.

Speakers:

• Pat Furlong: PPMD Founding President & CEO

• Stuart W. Peltz, PhD: CEO, PTC Therapeutics

• Mark E. Boulding: EVP and Chief Legal Officer, PTC Therapeutics

• Craig McDonald, MD: UC Davis

To Participate:

1. Visit ReadyTalk.com and use participant code 9449985. (Be sure to test your computer beforehand)
2. Audio Dial-In Information:
   • U.S. & Canada: Dial 1.866.740.1260 and use the Access Code 9449985
   • Outside the U.S. and Canada: Lookup your number

Submit Questions:

Please submit questions in advance to info@parentprojectmd.org, with “PTC Webinar” in the subject line by noon on Thursday, 7/28.